Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System

Akagi "Evaluation of desialylation effect on zeta potential of extracellular vesicles secreted from human prostate cancer cells by on-chip microcapillary electrophoresis." Jpn. J. Appl. Phys. (2014) 10.7567/jjap.53.06jl01

[2]

Alvarez-Erviti "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes." Nat. Biotechnol. (2011) 10.1038/nbt.1807

[3]

Batrakova "Using exosomes, naturally-equipped nanocarriers, for drug delivery." J. Control. Release (2015) 10.1016/j.jconrel.2015.07.030

[4]

Bhang "Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells." Biomaterials (2011) 10.1016/j.biomaterials.2010.12.035

[5]

Bian "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model." J. Mol. Med. (2014) 10.1007/s00109-013-1110-5

[6]

Börger "Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents." Int. J. Mol. Sci. (2017) 10.3390/ijms18071450

[7]

Bruno "Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury." PLoS One (2012) 10.1371/journal.pone.0033115

[8]

Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury

Stefania Bruno, Cristina Grange, Maria Chiara Deregibus et al.

Journal of the American Society of Nephrology 2009 10.1681/asn.2008070798

[9]

Mesenchymal stem cells as trophic mediators

Arnold I. Caplan, James E. Dennis

Journal of Cellular Biochemistry 2006 10.1002/jcb.20886

[10]

Carmelo "A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue." Biotechnol. J. (2015) 10.1002/biot.201400586

[11]

Cha "Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells." Sci. Rep. (2018) 10.1038/s41598-018-19211-6

[12]

Conlan "Exosomes as reconfigurable therapeutic systems." Trends Mol. Med. (2017) 10.1016/j.molmed.2017.05.003

[13]

Costa "Tridimensional configurations of human mesenchymal stem/stromal cells to enhance cell paracrine potential towards wound healing processes." J. Biotechnol. (2017) 10.1016/j.jbiotec.2017.09.020

[14]

Croughan "Novel single-use bioreactors for scale-up of anchorage-dependent cell manufacturing for cell therapies" Stem Cell Manufacturing (2016) 10.1016/b978-0-444-63265-4.00005-4

[15]

da Silva Meirelles "Mechanisms involved in the therapeutic properties of mesenchymal stem cells." Cytokine Growth Factor Rev. (2009) 10.1016/j.cytogfr.2009.10.002

[16]

de Almeida Fuzeta "Addressing the manufacturing challenges of cell-based therapies" Advances in Biochemical Engineering/Biotechnology (2019) 10.1007/10_2019_118

[17]

de Soure "Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells." J. Biotechnol. (2016) 10.1016/j.jbiotec.2016.08.007

[18]

de Soure "Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells." J. Tissue Eng. Regen. Med. (2017) 10.1002/term.2200

[19]

de Sousa Pinto "Scalable manufacturing of human mesenchymal stromal cells in the vertical-wheel bioreactor system: an experimental and economic approach." Biotechnol. J. (2019) 10.1002/biot.201800716

[20]

Doeppner "Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression." Stem Cells Transl. Med. (2015) 10.5966/sctm.2015-0078

[21]

dos Santos "Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia." J. Cell. Physiol. (2010) 10.1002/jcp.21987

[22]

dos Santos "A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem / stromal cells." Biotechnol. Bioeng. (2014) 10.1002/bit.25187

[23]

Doucet "Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications." J. Cell. Physiol. (2005) 10.1002/jcp.20391

[24]

Eibes "Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system." J. Biotechnol. (2010) 10.1016/j.jbiotec.2010.02.015

[25]

El Andaloussi "Exosomes for targeted siRNA delivery across biological barriers." Adv. Drug Deliv. Rev. (2013) 10.1016/j.addr.2012.08.008

[26]

Elahi "Preclinical translation of exosomes derived from mesenchymal stem/stromal cells." Stem Cells (2020) 10.1002/stem.3061

[27]

Fang "Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 pathway during wound healing." Stem Cells Transl. Med. (2016) 10.5966/sctm.2015-0367

[28]

Frauenschuh "A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells." Biotechnol. Prog. (2007) 10.1021/bp060155w

[29]

Gardiner "Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis." J. Extracell. Vesicles (2013) 10.3402/jev.v2i0.19671

[30]

Golpanian "Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease." Stem Cells Transl. Med. (2016) 10.5966/sctm.2015-0101

[31]

Exosomes as drug delivery vehicles for Parkinson's disease therapy

Matthew J. Haney, Natalia L. Klyachko, Yuling Zhao et al.

Journal of Controlled Release 2015 10.1016/j.jconrel.2015.03.033

[32]

Haraszti "Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity." Mol. Ther. (2018) 10.1016/j.ymthe.2018.09.015

[33]

Heathman "The translation of cell-based therapies: clinical landscape and manufacturing challenges." Regen. Med. (2015) 10.2217/rme.14.73

[34]

Hemeda "Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells." Cytotherapy (2014) 10.1016/j.jcyt.2013.11.004

[35]

Hildner "Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: a comparison with articular chondrocytes." J. Tissue Eng. Regen. Med. (2015) 10.1002/term.1649

[36]

Hofbauer "Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells." Cytotherapy (2014) 10.1016/j.jcyt.2014.04.009

[37]

Hood "Maximizing exosome colloidal stability following electroporation." Anal. Biochem. (2014) 10.1016/j.ab.2013.12.001

[38]

Huang "Gamma irradiation of human platelet lysate: validation of efficacy for pathogen reduction and assessment of impacts on hpl performance." Cytotherapy (2019) 10.1016/j.jcyt.2019.03.498

[39]

Jeppesen "Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors." Proteomics (2014) 10.1002/pmic.201300452

[40]

Jia "Biomaterials NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo." Biomaterials (2018) 10.1016/j.biomaterials.2018.06.029

[41]

Keshtkar "Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine." Stem Cell Res. Ther. (2018) 10.1186/s13287-018-0791-7

[42]

Kesimer "Physical characterization and profiling of airway epithelial derived exosomes using light scattering." Methods (2015) 10.1016/j.ymeth.2015.03.013

[43]

Kim "Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells." Nanomedicine (2016) 10.1016/j.nano.2015.10.012

[44]

Kim "Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations." Nanomedicine (2018) 10.1016/j.nano.2017.09.011

[45]

King "Hypoxic enhancement of exosome release by breast cancer cells." BMC Cancer (2012) 10.1186/1471-2407-12-421

[46]

Kinzebach "Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cells." BMC Cell Biol. (2013) 10.1186/1471-2121-14-48

[47]

Kooijmans "PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time." J. Control. Release (2016) 10.1016/j.jconrel.2016.01.009

[48]

Kooijmans "Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach." Nanoscale (2018) 10.1039/c7nr06966a

[49]

Kordelas "MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease." Leukemia (2014) 10.1038/leu.2014.41

[50]

Lai "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury." Stem Cell Res. (2010) 10.1016/j.scr.2009.12.003

Showing 50 of 88 references

Cited By

157

Effects of Hydrogels on Mesenchymal Stem/Stromal Cells Paracrine Activity and Extracellular Vesicles Production

Oscar Fabian Garcia‐Aponte, Simon Kahlenberg · 2025

Journal of Extracellular Vesicles

Engineerable mesenchymal stem cell-derived extracellular vesicles as promising therapeutic strategies for pulmonary fibrosis

Yixiang Chen, Moxuan Li · 2025

Stem Cell Research & Therapy

Extracellular vesicle biogenesis of three‐dimensional human pluripotent stem cells in a novel Vertical‐Wheel bioreactor

Laureana Muok, Li Sun · 2024

Journal of Extracellular Biology

A roadmap towards manufacturing extracellular vesicles for cardiac repair

Ana F. Louro, Ana Meliciano · 2024

Trends in Biotechnology

Cell culture‐derived extracellular vesicles: Considerations for reporting cell culturing parameters

Faezeh Shekari, Faisal J. Alibhai · 2023

Journal of Extracellular Biology

Production of Mesenchymal Progenitor Cell-Derived Extracellular Vesicles in Suspension Bioreactors for Use in Articular Cartilage Repair

Jolene Phelps, Catherine Leonard · 2022

Stem Cells Translational Medicine

Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review

Chiew Yong Ng, Li Ting Kee · 2022

International Journal of Molecular...

Metrics

157

Citations

88

References

Details

Published: Nov 03, 2020
Vol/Issue: 8
License: View

Authors

M

Miguel de Almeida Fuzeta

Nerve Regeneration Group, Porto, Portugal; i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; ICBAS- Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; Neuroengineering and Computational Neuroscience Group, INEB- Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal

A

Ana Fernandes-Platzgummer

J

José Paulo Farinha

C

Carlos A. V. Rodrigues

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5

M

Miguel A. R. B. Castanho

Cláudia Lobato da Silva

Funding

Fundação para a Ciência e a Tecnologia

Cite This Article

Miguel de Almeida Fuzeta, Nuno Bernardes, Filipa D. Oliveira, et al. (2020). Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System. Frontiers in Cell and Developmental Biology, 8. https://doi.org/10.3389/fcell.2020.553444

Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System

You May Also Like